INTRODUCTION
ATISFACTORY treatment of cancer of the thyroid depends not upon static morphologic standards but on a dynamic concept based upon an understanding of the biologic characteristics of these tumors. The physician faced with the problem of thyroid malignancy needs the answers to questions regarding the functional and biologic potential rather than a microscopic description of dead tissue. Of itself, the histology of a tumor has no value unless it can be utilized to predict how the cells of the tumor will act.
This concept of cancer as living tissue is particularly important in any study of thyroid cancer because of the biologic and histologic variability of the tumors, the protean manifestations of the disease, the endocrinologic aspects of many of the tumors and the availability of isotopic iodine for use in study and treatment.
The present study consists in the evaluation of 190 cases with an established diagnosis of cancer of the thyroid which were admitted to the Massachusetts General Hospital from 1931 through 1951. The objective was the accumulation of information which would help to direct our therapy along rational lines, based on the biologic characteristics of the various types of tumors.
CLASSIFICATION
One of the difficulties in evaluating reports on cancer of the thyroid has been a lack of a uniform classification of the disease. It is well recognized that there are at least three and possibly four major divisions into which cancers of the thyroid may be reasonably grouped, on the basis of both biologic characteristics and pathologic criteria. It has also been recognized, however, that the general classification into papillary carcinoma, adenocarcinoma, and anaplastic carcinoma has not been completely satisfactory; and there has been little agreement in terminology in the various subdivisions which have been described in the past. The use of strict morphologic criteria for the classification of tumors frequently fails to take into consid- . SEX AND AGE INCIDENCE,
FIVE-YEAR SURVIVALS AND DEATHS
The five-year survival percentage in this table is a simple arithmetical calculation; the cumulative five-year survival rate for each type, a more significant representation of the data, maj r be found in Tables 3, 4 eration the biologic characteristics of the various types of cancer, and it is this biologic individuality which is of the greatest importance to the physician who is attempting to treat the disease on a rational basis. Nonetheless, some form of classification must be used or complete disorganization will result. The classification which we present in this report appears in Table 1 . It is almost identical with that proposed by Warren and Meissner in the Atlas of Tumor Pathology (Section IV) published under the auspices of the Armed Forces Institute of Pathology (1) .
The general adoption of this classification by Warren and Meissner is to be recommended, since it employs a terminology which is satisfactory, accurate and descriptive. It is important, however, to recognize the limitations of any arrangement of this type. In comparing the biologic characteristics of our series of thyroid tumors with the microscopic classification, it is apparent that there is considerable overlap among the categories. For example, 7 of the papillary tumors showed distant metastases which clinically and functionally resembled follicular carcinoma, and at least 1 of the localized carcinomas in a follicular adenoma metastasized directly to regional nodes. Other examples could be cited but, in general, the classification of the tumors by these histologic criteria compared reasonably well with any classification of this particular series based on similarities in biologic and functional characteristics.
Photomicrographs of typical tumors from these categories are shown in Figure 1 .
The differentiated cancers of the thyroid have two main subdivisions: the papillary carcinomas and the follicular carcinomas. The papillary carcinomas require little further explanation. Microscopically these tumors reproduce to some extent the normal architecture of the thyroid but demonstrate many papillary inf oldings and proliferations which have long been recognized as a distinguishing feature of this type of cancer. The clinical characteristics of the papillary type will be discussed further under a separate heading. The term follicular carcinoma has been adopted for many reasons. Some differentiation of this tumor into typical thyroid, follicles is almost always apparent in histologic sections. From the point of view of the accepted definition of the word follicular, it is preferable to either alveolar or acinar-terms which have been applied to this type of cancer in the past. The term follicle refers to a closed epithelial sac, whereas acinus and alveolus have been used interchangeably for the saccular or tubular termination of the duct of a racemose gland. It seems reasonable to adopt the term follicular carcinoma as the nomenclature. Within this group of follicular carcinomas, however, it has long been apparent that there are at least two different types of tumors, if one considers the classification on the basis of biologic characteristics. Some of these tumors have a typical micro- scopic appearance of malignancy, and clinically this group will ordinarily be highly invasive locally and may be lethal because of invasion of adjacent structures. In addition, there is a type which microscopically has few, if any, of the established criteria of malignancy but does have the biologic characteristic of producing distant skeletal or pulmonary metastases which may ultimately bring about death, even though the primary tumor never goes on to local invasion beyond the limits of its capsule. Admittedly, in many cases it is difficult to decide into which of the sub-groups an individual tumor belongs. With these obvious limitations, however, we have further attempted to subdivide the main group of follicular carcinomas into the localized carcinomas arising in a follicular adenoma and into the adenocarcinomas which show the typical invasive characteristics of cancer both microscopically and grossly. By the use of this type of classification the term malignant adenoma, which by definition is paradoxical, has been avoided. Further discussion of these types of thyroid cancer will be included in a subsequent section.
The undifferentiated cancers of the thyroid have been divided into two groups, the small-cell type and the giant-cell type. These divisions are made strictly on the basis of microscopic characteristics, because the biologic characteristics of these tumors are almost identical. Again these undifferentiated cancers will be considered further in a subsequent section.
Under a third main group have been included the unusual malignant tumors of the thyroid which have occurred in this series of cases. The terms epidermoid carcinoma, fibrosarcoma and lymphoma are in such common usage as to be self-explanatory. The single Hurthle-cell carcinoma in this series has also been placed under this main heading. The biologic behavior of this tumor, however, suggests that, had we more experience, this type should be classified as a follicular carcinoma.
As may be seen from the data presented in Table 1 , there is a striking difference in the sex and age incidence, the five-year survival rate, and the frequency of the various types of tumor. These differences will be considered subsequently. METHODS 
1.
Basis of entry into study. All cases with a clinical or pathologic diagnosis of thyroid cancer in the Massachusetts General Hospital between 1931 and 1951 were reviewed. Both the clinical data and the pathologic sections were re-evaluated and the diagnosis of thyroid cancer confirmed before inclusion in the study. Patients entered the study on the date of the first procedure in the Massachusetts General Hospital that provided a histologic diagnosis. Some of the cases had been treated before entry to this hospital. The histologic diagnosis was in some cases made in other hospitals: in these instances, entry into the study was the date of admission.
2. Follow-up. Whenever the hospital record did not provide the date and cause of death for a patient, recent information about his subsequent course was sought by letters to the patient, his family, his personal physician or the municipal authorities. In preparing the mortality table all patients were classified as either "dead" or "lost to follow-up." The date of the last information about a patient is his date of entry into the category termed "lost to follow-up." Column 3 in Tables 3, 4 and 5 presents a frequency distribution of the duration of follow-up.
3. Methods of presenting data. Tables 3, 4 and 5 are mortality tables calculated in a standard manner (2, 3) . The legend under Table 3 describes the method of calculation. There are distinct advantages inherent in this method:
a. Complete information about the period of follow-up is provided, as just described. b. Interval survival rates are readily calculated from the cumulative survival rates. The cumulative survival rate ranging from entry into the series to year B, divided by the rate to year A, gives the probability of surviving from year A following entry to year B.
c. "Five-year cure rates" are usually calculated only on the basis of patients followed for five years or longer. Therefore, patients are discarded who provide information on the probability of surviving only from the time of entry into the study through the fourth year, because of "insufficient follow-up." By using the data that are usually discarded, it is possible to make a better estimate of the proportion of all patients who will survive from the end of the fourth to the fifth anniversary of entry into the study. By calculating survival rates for each time period, patients do not need to be discarded until their follow-up no longer provides information. By accumulating these "period survival rates" (the probability of surviving one period multiplied by the probability of surviving the next, and so on) one arrives at a probability for five-year survival that is a better estimate than the one calculated only on the basis of cases followed for five years or more.
d. The mortality-table technique has further advantages for other types of data; it was thought wise to adopt a technique which would be useful for comparison with other series.
GENERAL CONSIDERATIONS
Certain generalizations in regard to cancer of the thyroid may be made on the basis of the data presented in Tables 1 and 2 and in Figure 2 .
It is apparent that all the forms of differentiated cancer of the thyroid are primarily diseases of women. This sex difference is not so apparent in the undifferentiated group, which apparently follows a more random sex distribution. With the exception of papillary carcinoma, cancer of the thyroid is a disease of the middle and later spans of life. Papillary cancer, however, has a relatively high incidence of occurrence in the earlier decades of life and has been found even in prepubertal children in this series.
There was a striking difference in mortality between the various types of cancer. As might be expected the differentiated form was much less lethal than the undifferentiated type; in the latter instance only 11 per cent of the patients have survived five years or longer. On the other hand, among the more differentiated tumors appreciable numbers of patients in this series have already survived five years and a relatively smaller proportion have died since their initial admission.
There are many statistical'fallacies, however, in calculating five-year survivals out of a limited group of patients who had the opportunity to survive five years; therefore, in Figure 2 cumulative survival curves have been plotted on the basis of the data shown in Tables 3, 4 , and 5. This type of calculation and graphic representation of the data should give a much more accurate picture of the survival rate of patients with a specific type of disease and therefore this figure should be of greater interest and significance in obtaining a proper understanding of the characteristics of the various types of thyroid cancer. It is apparent from Figure 2 that there is a striking difference between the prognosis of papillary carcinoma and that of Column 1. "Time period ending at 2 years" means the 6-month period preceding the second anniversary of entry into the study. The only time periods shown, are those during which a patient died from thyroid cancer or was "lost to follow-up."
Column 2. When a blank occurs, there was no death in the time period. Column 3. See paragraph headed "Follow-up" in the text. Column 4-Patients entering the preceding time period, less the deaths and losses in the preceding period.
Column 5. Column 4, less one half of Column 3. Calculations are only for time periods in which there was a death from cancer.
Column 6. Column 2 divided by Column 5 and subtracted from 100. In time periods in which there was no cancer death the survival rate is 100 per cent, but this is omitted for clarity.
Column 7. The probability (in per cent) of surviving from the time of entry into the study to the time in Column 1. It changes only in the periods in which there was a cancer death. Omitted figures are the same as the Column 6 probability. Calculations are made by multiplying the cumulative survival rate of the preceding time-period (Column 7) by the current time-period survival rate (Column 6). undifferentiated carcinoma. Perhaps the most interesting feature of this particular graph is the biphasic character of the survival curve plotted for the follicular carcinomas. If one examines the data carefully it is apparent that over half of the deaths from follicular carcinoma occurred within the first two years after the diagnosis had been established. Most of these deaths resulted from local invasion by the cancer. Then there was a latent period for another two and a half years, during wliich none of the patients with follicular carcinoma died. At about the five-year point another series of deaths occurred and continued to occur over the subsequent decade. This would suggest that there are two different types of cancer under this general heading of follicular carcinoma, and this impression is borne out by a more careful individual analysis of these cases. This problem will be discussed at greater length under a subsequent heading.
There is nothing in the data presented in this report which has any bear- ing on the incidence of thyroid cancer in the population at large, nor is there any attempt to evaluate the incidence of cancer in nodular goiter or in solitary nodules of the thyroid. Nonetheless, some of the information presented in Table 2 is of interest in regard to the pathogenesis of thyroid cancer. It is striking that a large percentage of these patients had pre-existing thyroid disease, and this information has been presented in a simplified form by reporting the number of patients who were known to have a goiter for more than three years before the diagnosis of thyroid cancer was first established. In the group of follicular carcinomas almost two thirds of the patients were known to have pre-existing thyroid disease three years or more before the diagnosis of thyroid cancer was established. Even in the papillary group, a third of the patients similarly evaluated had pre-existing thyroid disease, and the inference would be that in regard to the differentiated types of thyroid cancer, either the malignant process had existed for many years before the diagnosis was made, or it arose in a thyroid already diseased. In the undifferentiated group a much smaller percentage of patients had a long-standing history of goiter. A large percentage of the total series of thyroid cancer showed demon-strable metastases at the time the diagnosis was established. In the papillary group, with few exceptions, these metastases were characterized as regional, i. e., the spread had occurred only to the lymph nodes in the neck or upper mediastinum. Therefore one might expect that papillary cancer would be more amenable to surgical resection, and that impression is borne out by the relatively high survival rate in this group. The follicular carcinomas, although locally resectable in almost as high a percentage of patients as the papillary carcinomas, were not surgically curable in almost half the cases even at the time of initial admission, because of distant metastases to the skeletal system or to the lungs. The undifferentiated group of cancers showed a high percentage of both regional and distant metastases and the degree of local invasion was apparent from the fact that only 27 per cent of this group were considered surgically resectable from the point of view of a direct attack on the primary tumor. There was a low hospital mortality in the entire group, since it was possible in a great majority of the cases to offer enough palliation so that the patient could be discharged, even though the disease was hopelessly incurable. It is important to note this very low hospital mortality because it is apparent that, in this group at least, very few patients died in a hospital and therefore a survey of the autopsy material at this hospital would give a false impression of the actual incidence of thyroid cancer.
The miscellaneous group of relatively rare thyroid cancers contained too few cases to warrant any conclusions, but a few observations are pertinent. In the small group of 5 epidermoid carcinomas, no patient survived more than one year after the diagnosis was made. The inference is, therefore, that epidermoid carcinoma arising in the thyroid is a highly malignant lesion and carries a poor prognosis. All the patients with lymphomas and fibrosarcomas which apparently arose in the thyroid died of their disease and the 1 patient with Hurthle-cell carcinoma is still living with slowgrowing skeletal metastases.
PAPILLARY CARCINOMA
The papillary carcinomas comprise the largest number of thyroid cancers-almost half of the entire series (Table 1) . They also have less malignant potential than any other group, inasmuch as the cumulative survival rate of this group is appreciably higher than in any other type of thyroid cancer (Fig. 2) , distant metastases are relatively rare (Table 2) , and the whole pattern of growth is relatively leisurely in nature. Biologically its behavior follows a closely prescribed pattern, with early metastases to the regional lymph nodes but with only rare instances of distant blood-borne metastases. It is this type of leisurely metastasis to the cervical chain of lymph nodes that formerly was called "aberrant thyroid tissue." Although the disease may be entirely localized to the thyroid at the time the initial diagnosis is made, many of the cases are brought to attention by the presence of metastatic nodules in a cervical chain of lymph nodes rather than by a palpable mass in the thyroid. As has been mentioned, distant metastases from papillary carcinomas of the thyroid are uncommon, but lungs or bones may be involved. Such occurred in 7 cases out of the total number of 89 papillary carcinomas. It is possible that in these rare instances of distant metastases there may have been an admixture of follicular elements. This impression is substantiated by the fact that one of these patients with diffuse pulmonary metastases showed a remarkable clinical improvement and x-ray regression following the administration of I 131 subsequent to total thyroidectomjr.
In Figure 3 the three major types of thyroid cancer have been broken down according to the age incidence and the mortality from the disease in each age group. This analysis of the papillary tumors is striking, inasmuch as it appears that this type of cancer has a different potential in the old than in the young. Although a high proportion of the total group with papillary tumors occurred in persons in the first four decades of life, only 3 patients who contracted the disease under the age of 50 have died as a result of this cancer. All the remaining patients who died of the disease were more than 50 years of age at the time the diagnosis was established. This is an unusual observation, inasmuch as most other types of cancer are more malignant when they appear in the young. These data substantiate similar observations made by Crile (4) in regard to the malignant potential of cancer of the thyroid relative to age.
With these data available, certain generalizations in regard to papillaĉ ancer of the thyroid are permissible. It is a disease which occurs in almost every decade of life but is, with rare exceptions, the only cancer of the thyroid which occurs in the first four decades of life. There is distinctly greater mortality from this disease if it is contracted over the age of 50. Papillaiy cancer of the thyroid tends to metastasize early to the regional lymph nodes, but also tends to remain localized to these areas and therefore is amenable to radical surgical excision in a high proportion of the cases. Distant metastases are rare and when they do occur may well be a result of a mixture of follicular elements in the primary tumor.
Rational treatment of papillary cancer of the thyroid would therefore depend on the age of the patient and the presence or absence of regional node metastases. For example, a young person with papillary cancer of the thyroid and palpable regional node metastases in the jugular chain should have a radical thyroidectomy*and neckdissection. Further radical surgery should be considered if contralateral metastases appear, or if the superior mediastinal nodes become involved. The presence of even widespread node metastases should not deter the surgeon from embarking on extensive surgery, because of the known fact that distant metastases are uncommon. Likewise in a young individual without any jobvious involvement of the regional nodes at the time of exploration of the thyroid it is probably unwise to carry out a relatively mutilating type of operation such as radical neck dissection. This statement may meet with strenuous objections, but in a disease which carries such a very low mortality in young individuals and which tends to demonstrate a leisurely and localized metastatic spread to regional nodes, it seems unjustifiable to subject such a patient to a socalled prophylactic regional node dissection.
In older individuals, however, the situation would appear to be different. Mortality from the disease when it occurs over the age of 50 is such that one could with justification advocate radical dissection of the regional nodes at the time of the initial resection of the thyroid tumor, regardless of whether or not these nodes were clinically involved with cancer. In view of our experience with a case of^papillarylcancer*in which extensive pulmonary metastases responded remarkably well to the administration of radioactive iodine (I 131 ) it would seem justifiable to administer this isotope for the treatment of distant metastases, even though the initial tumor was microscopically papillary in type and showed no appreciable uptake. From all the information available in this series of 89 cases of papillary cancer of the thyroid, this is the type of cancer which is actually curable in a large percentage of cases, provided a rational approach to the disease is undertaken and persistent attempts are made to eradicate local metastases whenever they appear.
FOLLICULAR CARCINOMA Under the heading of follicular carcinoma have been grouped all those cancers of the thyroid in which there was microscopic evidence of some degree of reproduction of follicular pattern. Microscopically these showed all degrees of malignancy, ranging from the tumors which would be considered benign microscopically were not distant metastases demonstrable, up to the obviously invasive adenocarcinomas. If these thyroid cancers are considered under the general heading of follicular carcinoma there are certain facts which can be evolved from these data. The sex incidence of this cancer shows that it is more than three times as common in the female as in the male, the age incidence shows that it is primarily a disease of the middle and later spans of life, and the five-year survival rate shows that it falls between the papillary and the undifferentiated types in terms of lethal potential. Seventy-five per cent of these cancers are technically resectable from the surgical point of view, so that the incidence of early invasion of surrounding structures is not high. Nonetheless, almost half of the cases had distant metastases at the time when the diagnosis was first established, showing that this tumor differs from the papillary lesions in that it cannot be considered to be surgically " curable" to as great a degree.
The fact that almost two thirds of the patients had pre-existing goiters for more than three years is particularly significant and suggests that this group of carcinomas in particular may well arise in diseased thyroid glands. The possibility that malignancy had existed in a leisurely and localized form for many years cannot be overlooked but it seemed more likely from the individual histories that most of these cases had had benign thyroid disease for many years before malignant change occurred.
It has been the opinion of the members of the Thyroid Clinic of the Massachusetts General Hospital for many years that there are probably two different types of so-called adenocarcinoma of the thyroid. In this series of cases we have attempted to evaluate this clinical impression and have divided the follicular carcinomas into two groups on the basis of microscopic criteria. One group consists of those cases which showed little if any evidence of malignancy on microscopic examination and had not broken through the surrounding capsule of the tumor; in fact in many of them the only evidence of malignancy was either the presence of invasion into blood vessels or the presence of distant metastases. In the second group, which has been called in Table 1 the follicular adenocarcinomas, there was distinct microscopic evidence of malignancy and evidence of local invasion well beyond the confines of any surrounding capsule. It has been interesting to see if there was any clinical distinction between these two histologic classifications. In the group of so-called localized carcinomas, only 3 patients died in less than two years after the diagnosis was established at this hospital. When these 3 were considered more closely it was apparent from their histories that the disease had existed for a much longer period of time; in 1 patient a diagnosis of cancer had been made at thyroidectomy at another hospital four years before her initial admission to the Massachusetts General Hospital, and in a second patient thyroid tissue had been found microscopically in a metastatic lesion in the vertebral column five 3'ears before he was first seen at this Clinic. Therefore out of this entire group there was only 1 patient who died less than two years after the diagnosis of thyroid cancer was first established. This presents a distinctly different clinical picture from that in the 26 patients with follicular adenocarcinoma, of whom 8 died in less than a year after the diagnosis was first established. Thus a good correlation existed between the microscopic criteria and the clinical course of the cases in these two groups. This division of the follicular carcinomas into two separate biologic entities is further substantiated by the appearance of the graphic representation of the cumulative survival rate of the total group of follicular carcinomas (Fig. 2) . The striking biphasic quality has already been noted. No such biphasic quality was seen in the curves of undifferentiated and papillary cancers.
From this information it seems reasonable to say that the follicular carcinomas, taken as a group, usually arise in diseased thyroid glands, that the incidence is predominantly in the female, that the local resectability rate is high, but the incidence of early distant metastases is also high. The total picture is, therefore, quite different from that of the papillary type of cancer, and rational treatment should be employed, with these considerations in mind. In this type of cancer, age does not determine the type of therapeutic approach, as it might in the papillary group. All patients in this group, however, should have at least a total thyroidectomy at the time of the initial exploration. There is a relatively low incidence of regional node metastases and, therefore, radical neck dissection should be considered only if demonstrable lymph node metastases exist. The high incidence of distant metastases makes it apparent that one cannot rely on surgical methods alone to control the disease.
In this particular type of thyroid cancer the rationale of thyroidectomy is twofold: 1) the eradication of the primary focus, and 2) ablation of functioning thyroid tissue in order that radiation therapy with I 131 may be employed to control the distant metastases. There was considerable hope that when I 131 became available, metastases from this type of follicular carcinoma would take up a high proportion of an administered dose of the isotope and thereby induce a high radiation potential in the metastatic lesion. In some cases treatment with I 131 after removal of the primary tumor has been remarkably effective. Nonetheless, it would be fair to say that the initial optimism has not been borne out in a long-term survey of these cases. Of the 14 cases of metastatic thyroid cancer treated with I 131 in this Clinic, 12 were classified as follicular carcinomas microscopically. The results of therap3' are shown in Table 6 . Six patients in this group were reported to show clinical improvement; but this interpretation was primarily subjective and only 1 of the patients with metastatic disease from the follicular carcinoma showed improvement by x-ray examination. Five of the 12 patients died of their disease and 1 was lost to follow-up. The other 6 patients have been living with evidence of disease for two years or more. One might say that this was evidence in itself that I 131 had been effective in controlling the growth of the metastatic lesions, and this statement may well be true; but it is important to realize that the natural history of these metastases from follicular carcinoma is one of a relatively leisurely rate of growth, and there are several patients in this series, with untreated metastases who survived man}' years. Without more objective evidence of the effect of I 131 on metastatic cancer of the thyroid, all that can be said is that results in this series of 14 cases are inconclusive. In 1 case already mentioned of metastatic pulmonary lesions from a primary papillary cancer of the thyroid, both clinical and x-ray improvement was rapid and dramatic. It is the impression of the members of this Clinic that 6 cases of follicular carcinoma were benefited by the use of I 131 , but without more objective evidence this can be classified only as a clinical impression and valued as such. After total thyroidectomy, thiouracil drugs were employed in 6 cases in order to improve the uptake of I 131 by the metastatic lesion. Apparently this was effective in at least 4 of these cases, if the change in total iodine uptake can be accepted as an index of the effect of thiouracil.
In summary, therefore, one can state that follicular cancer of the thyroid probably consists of two separate biologic entities. One type has characteristics of early invasion of surrounding structures and the patient has a relatively short duration of life if the disease cannot be surgically eradicated in its early stages. The other type is benign from the point of view of its local invasiveness, but early in its course shows distant metastases which may be ultimately lethal over a period of many years. Regardless of the histologic type of the tumor, the approach should be initially an attempt to cure the disease surgically by total thyroidectomy, with radical neck dissection only in the cases in which there are demonstrable lymph node metastases. Further therapy should depend upon the presence of demonstrable distant metastases. If these exist, the total ablation of normal thyroid function is important, since at present the only hope of control of the disease is the administration of I 131 after a period of thiouracil therapy to induce a greater uptake by the metastatic lesion. It should be mentioned briefly that some of these metastatic lesions have been surgically resectable. This is something to be considered in every case, since the presence of one or two metastases in this type of cancer does not necessarily mean widespread invasion of the entire organism. UNDIFFERENTIATED 
CARCINOMA
In the past, many terms have been applied to various subdivisions of this group of cancers, e.g., carcinoma simplex, round-cell carcinoma or anaplastic carcinoma. The common denominator of this group is that none shows any microscopic evidence of attempts to reproduce distinguishable thyroid structure. All of them appear to have a highly malignant potential and it seems reasonable to consider them all under the heading of undifferentiated carcinoma.
Microscopically there are two different types: one is composed of highly anaplastic giant cells often resembling sarcoma, and the other of small cells growing in either a compact or a diffuse arrangement. This subdivision is strictly morphologic, however, since there are no apparent distinguishing biologic characteristics.
From the data presented in Tables 1 and 2 and in Figures 2 and 3 , it is apparent that these undifferentiated cancers occur only rarely before middle age, that the preponderance in the female is less striking than it is in the differentiated tumors, and that the mortality from the disease is high.
These tumors grow rapidly and invade surrounding structures so early that only 27 per cent of the total group of 45 cases were surgically resectable at the initial admission. Nonetheless, of the 12 patients whose tumors were considered resectable, 5 are living and well more than four years after operation. Therefore, although the over-all prognosis of these tumors is poor and 70 per cent of the patients died in less than a year after the diagnosis was made, the situation is not inevitably hopeless and a wide resection of an operable tumor offers some chance of salvage. In most cases, however, all the surgeon can accomplish is to free the trachea from the garrot of tumor tissue by resecting the isthmus. External radiation has been employed frequently but there was no evidence in this series that any palliation was achieved.
SUMMARY AND CONCLUSIONS 1. In the twenty years from 1931 to 1951, 190 patients with malignant disease of the thyroid gland were admitted to the Massachusetts General Hospital.
2. These cancers have been classified according to a method described by Warren and Meissner, which utilizes accurate terminology and takes
